Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro

Blood

Volumn 115, Issue 1, 2010, Pages 151-153

  Rutten, Caroline E ^a   Van Luxemburg Heijs, Simone A P ^a   Van Der Meijden, Edith D ^a   Griffioen, Marieke ^a   Oudshoorn, Machteld ^a   Willemze, Roel ^a   Frederik Falkenburg, J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DPB1 ANTIGEN; HLA DP ANTIGEN;

GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; LETTER; PRIORITY JOURNAL; RISK FACTOR; STEM CELL TRANSPLANTATION; ALLELE; GENETICS; HELA CELL; HISTOCOMPATIBILITY TEST; IMMUNE SYSTEM; IMMUNOLOGY;

ALLELES; HELA CELLS; HISTOCOMPATIBILITY TESTING; HLA-DP ANTIGENS; HUMANS; IMMUNE SYSTEM;

EID: 74949100644     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-10-249821     Document Type: Letter

References (6)

1. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110(13):4576-4583.
2. Shaw BE, Gooley TA, Malkki M, et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood. 2007;110(13):4560- 4566.
3. Crocchiolo R, Zino E, Vago L, et al. Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood. 2009;114(7):1437-1444.
4. Zino E, Frumento G, Marktel S, et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines non-permissive mismatches for hematologic stem cell transplantation. Blood. 2004;103(4):1417-1424.
5. Ludajic K, Balavarca Y, Bickeboller H, et al. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT. Br J. Haematol. 2008;142(3):436-443.
6. Shaw BE, Fleischhauer K, Zino E, et al. Significant differences in outcome after unrelated donor HCT can be better predicted using an algorithm incorporating both allele and epitope level matching for HLA-DPB1 [abstract]. Bone Marrow Transplant. 2009;43(suppl 1s):78. Abstract 416.